Castle Biosciences Inc (NAS:CSTL)
$ 24.37 0.63 (2.65%) Market Cap: 672.79 Mil Enterprise Value: 458.63 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 79/100

Castle Biosciences Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 19, 2023 / 08:30PM GMT
Release Date Price: $23.56 (+3.29%)
Mike Matson
Needham & Company - Analyst

Good afternoon. Thanks for sticking around and joining us again at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson and I lead the medtech and diagnostics equity research team at Needham & Company.

I'm pleased to introduce Castle Biosciences. Presenting for Castle, we have CEO, Derek Maetzold; CFO, Frank Stokes; and Vice President, Investor Relations and Corporate Affairs, Camilla Zuckero. They're going to give a presentation on Castle and then we should have some time for questions for the end.

If you do have any questions that you would like to ask, you can submit them electronically through the Needham conference website or feel free to email them to me at [email protected], and I'll do my best to fit them.

So with that, I'll turn it over to Derek. Thanks.

Derek Maetzold
Castle Biosciences, Inc. - Founder, President & CEO

Thank you, Mike, for introductions. It is a pleasure to join the Needham Healthcare Conference this year again. I've put together just a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot